GE chief Culp sells biopharma business for $21.4 billion

Shares of General Electric Co surged 15 percent on Monday after the industrial conglomerate said it would sell its biopharma business to Danaher Corp for $21.4 billion, its first major asset sale under new Chief Executive Officer Larry Culp.